ICON Joins Groundbreaking Genome Initiative

Brendan Buckley, chief medical officer for ICON.
Brendan Buckley, chief medical officer for ICON.

By Julia Brodsky, Editorial Assistant
April / May 2016

ICON plc was recently selected by Genomics England to support their “100,000 Genomes” project, the world’s largest genome sequencing project for cancer and rare diseases, which could revolutionize the diagnosis and treatment of various cancers and rare diseases.

Announced by British Prime Minister David Cameron in 2012, the project will compile 100,000 whole genomes from 70,000 individual National Health Service (N.H.S.) patients and their families. This data, once sequenced and de-identified, will become available to approved researchers who will assist in developing tools for diagnosis and treatment based on individual patients’ genetic characteristics. It is currently the largest project of its kind worldwide.

ICON, a company that offers drug development solutions to the medical industries, is headquartered in Dublin and will use its substantial data management capabilities to support and organize the clinical data collected from the 70,000 patients and their families.

“Our partnership with Genomics England demonstrates our commitment to partnering with industry and government organizations in new and innovative ways to improve patient care by accelerating the development of targeted and personalized medicines that tackle complex diseases,” said Professor Brendan Buckley, ICON’s Chief Medical Officer (left).

Managing Director for the 100,000 Genomes project, James Peach, was equally enthusiastic about the partnership. “We are delighted to be partnering with ICON,” he said.

“Their renowned expertise in data management will be fundamental in driving scientific research and accelerating the return of results for N.H.S. patients.” ♦

Leave a Reply




Share



More Articles

Dr. William Campbell, who received the Nobel Prize in Medicine last year. Photo courtesy Drew University.
William Campbell’s Nobel Prize

Donegal native Dr. William Campbell was awarded the Nobel Prize in medicine for his work on a drug that fights...

More

Murray Ciaran
Ciarán Murray

Ciarán Murray is the chief executive officer of ICON Plc., a global leader in clinical research and one of Ireland’s...

More

Professors Brian Lawlor (left) and Ian Robertson, who will head the new Trinity research project.
Weekly Comment:
Trinity Receives Largest Donation in Irish History

The Atlantic Philanthropies, created in 1982 by Irish-American businessman Chuck Feeney, is giving  €138.4 million...

More

Ciaran Murray Announces New ICON Innovation Hub earlier this year.  (Picture by Shane O'Neill / Copyright Fennell Photography 2015.)
Ireland’s Action Plan for Jobs
Brings Results

In his April 28th Spring Economic Statement speech, Finance Minister Michael Noonan T.D. announced that Ireland...

More